These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10078661)

  • 1. How carefully can we phenotype patients suspected of malignant hyperthermia susceptibility?
    Larach MG; MacLennan DH
    Anesthesiology; 1999 Mar; 90(3):645-8. PubMed ID: 10078661
    [No Abstract]   [Full Text] [Related]  

  • 2. [Malignant hyperthermia].
    Glahn KP
    Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility.
    Hopkins PM; Rüffert H; Snoeck MM; Girard T; Glahn KP; Ellis FR; Müller CR; Urwyler A;
    Br J Anaesth; 2015 Oct; 115(4):531-9. PubMed ID: 26188342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia.
    Glisson SN
    Compr Ther; 1988 Oct; 14(10):33-41. PubMed ID: 3053015
    [No Abstract]   [Full Text] [Related]  

  • 5. Genomic Screening for Malignant Hyperthermia Susceptibility.
    Biesecker LG; Dirksen RT; Girard T; Hopkins PM; Riazi S; Rosenberg H; Stowell K; Weber J
    Anesthesiology; 2020 Dec; 133(6):1277-1282. PubMed ID: 32898259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurological aspects of malignant hyperthermia. Clinics, physiopathology, genetics].
    Serratrice G; Kozak-Ribbens G; Cozzone PJ
    Rev Neurol (Paris); 1997 Jun; 153(5):304-13. PubMed ID: 9296164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal diagnosis of malignant hyperthermia susceptibility.
    Girard T; Jöhr M; Schaefer C; Urwyler A
    Anesthesiology; 2006 Jun; 104(6):1353-4. PubMed ID: 16732128
    [No Abstract]   [Full Text] [Related]  

  • 8. Detecting susceptibility to malignant hyperthermia.
    Ellis FR
    BMJ; 1992 Mar; 304(6830):791-2. PubMed ID: 1392703
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia.
    Urwyler A; Deufel T; McCarthy T; West S;
    Br J Anaesth; 2001 Feb; 86(2):283-7. PubMed ID: 11573677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing malignant hyperthermia susceptibility.
    Hopkins PM; Halsall PJ; Ellis FR
    Anaesthesia; 1994 May; 49(5):373-5. PubMed ID: 8209973
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis of susceptibility to malignant hyperthermia in man.
    Ording H
    Br J Anaesth; 1988 Feb; 60(3):287-302. PubMed ID: 3279989
    [No Abstract]   [Full Text] [Related]  

  • 12. Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia?
    Ellis FR; Halsall PJ; Hopkins PM
    Br J Anaesth; 1992 Nov; 69(5):468-70. PubMed ID: 1467078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and susceptibility to malignant hyperthermia.
    Anderson-Pompa K; Foster A; Parker L; Wilks L; Cheek DJ; Mill TD; Dore M; McSherry G
    Crit Care Nurse; 2008 Dec; 28(6):32-6; quiz 37. PubMed ID: 19047693
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetics of malignant hyperthermia.
    Brandom BW
    ScientificWorldJournal; 2006 Dec; 6():1722-30. PubMed ID: 17195870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Masseter muscle spasm and the diagnosis of malignant hyperthermia susceptibility.
    Ellis FR; Hopkins PM; Halsall PJ; Christian AS
    Anesth Analg; 1992 Jul; 75(1):143-6. PubMed ID: 1616144
    [No Abstract]   [Full Text] [Related]  

  • 16. The genetic basis of malignant hyperthermia.
    Greenbaum I; Weigl Y; Pras E
    Isr Med Assoc J; 2007 Jan; 9(1):39-41. PubMed ID: 17274355
    [No Abstract]   [Full Text] [Related]  

  • 17. [The approach to patients susceptible to malignant hyperthermia].
    Ben Abraham R; Glauber V; Cahaba A; Perel A
    Harefuah; 1998 May; 134(9):736-9. PubMed ID: 10909627
    [No Abstract]   [Full Text] [Related]  

  • 18. "Noninvasive" testing for malignant hyperthermia susceptibility.
    Allen PD; López JR
    Anesthesiology; 2002 Nov; 97(5):1045-6. PubMed ID: 12411783
    [No Abstract]   [Full Text] [Related]  

  • 19. Spectrum of susceptibility to malignant hyperthermia--diagnostic dilemma.
    Nelson TE; Flewellen EH; Gloyna DF
    Anesth Analg; 1983 Jun; 62(6):545-52. PubMed ID: 6846875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant hyperthermia as a complication of anesthesia: predisposition is hereditary].
    Snoeck MM; Gielen MJ; Sengers RC; Padberg GW; Iles DE; Booij LH
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):616-9. PubMed ID: 9190536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.